- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: revlimid
Total 628 results
-
Stichting Hemato-Oncologie voor Volwassenen NederlandUMC Utrecht; Amsterdam University Medical Centers; The Dutch Network for Cardiovascular...Not yet recruitingDLBCL - Diffuse Large B Cell LymphomaNetherlands
-
M.D. Anderson Cancer CenterPfizerNot yet recruitingMultiple Myeloma | Post-transplant MRD-guided Maintenance Therapy | Pre-transplant PurgingUnited States
-
OncotherapeuticsIncyte CorporationNot yet recruiting
-
National Cancer Institute (NCI)Recruiting
-
Regeneron PharmaceuticalsRecruitingRelapsed/Refractory Follicular Lymphoma | Marginal Zone Lymphoma (MZL)Korea, Republic of, Australia, Spain, Malaysia, France, Taiwan, Italy, Poland, United States, Thailand, United Kingdom, Turkey, Belgium, Czechia
-
Wuhan Union Hospital, ChinaRecruitingMultiple Myeloma | Extramedullary Multiple Myeloma | Primary Plasma Cell LeukemiaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingFollicular LymphomaUnited States
-
Bristol-Myers SquibbRecruitingMultiple MyelomaAustria, Spain, Australia, United States, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Poland, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom
-
Mayo ClinicRecruiting
-
Peking Union Medical College HospitalHenan Cancer Hospital; Shengjing Hospital; Sun Yat-Sen Memorial Hospital of Sun... and other collaboratorsNot yet recruitingGestational Trophoblastic NeoplasiaChina
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGeneRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | Pleomorphic Variant Mantle Cell LymphomaUnited States
-
Amany Keruakous, MD, MS.Not yet recruiting
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
Washington University School of MedicineKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Myeloma-Associated AmyloidosisUnited States
-
David Bond, MDRecruitingRecurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Recurrent... and other conditionsUnited States
-
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.Not yet recruitingB-cell Non-Hodgkin's Lymphoma
-
Medical College of WisconsinRecruiting
-
M.D. Anderson Cancer CenterDaiichi SankyoRecruiting
-
GenmabAbbVieRecruitingDiffuse Large B Cell LymphomaFrance, Korea, Republic of, Spain, Belgium, Japan, Germany, Czechia, United Kingdom, Italy, Austria, United States, Poland
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
M.D. Anderson Cancer CenterRecruitingHodgkin Lymphoma | B-Cell Lymphoma | Relapsed B-cell NHLUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Recruiting
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | ISS Stage III Plasma Cell MyelomaUnited States
-
Dong-A University HospitalAmgenNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Irene Ghobrial, MDJanssen Research & Development, LLCRecruitingMultiple Myeloma | Smoldering Multiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Xia ZhongjunAntengene CorporationRecruiting
-
James RubensteinIncyte CorporationRecruitingPrimary Central Nervous System Lymphoma | CNS Lymphoma | Secondary Central Nervous System LymphomaUnited States
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterGenzyme, a Sanofi CompanyRecruitingCancer | Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
BeiGeneRecruitingMarginal Zone Lymphoma | Relapsed/Refractory Follicular LymphomaUnited States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
-
M.D. Anderson Cancer CenterRecruiting
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
M.D. Anderson Cancer CenterRecruitingRefractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
Juan DuRecruitingMultiple MyelomaChina
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoma | Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin LymphomaUnited States
-
EnteromeRecruitingFollicular Lymphoma | Marginal Zone LymphomaUnited States, Italy, Spain
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
CelgeneRecruitingLymphoma NonhodgkinJapan
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingPlasma Cell Myeloma | RISS Stage I Plasma Cell Myeloma | RISS Stage II Plasma Cell MyelomaUnited States
-
Mikkael Sekeres, MDBristol-Myers Squibb; CelgeneRecruitingMyelodysplastic SyndromesUnited States
-
OncotherapeuticsKaryopharm Therapeutics IncRecruitingRefractory Multiple MyelomaUnited States